CGMP RE-SUPPLY OF HPV 16L1/16RG1

$8.55M USD

Funder	NATIONAL CANCER INSTITUTE
Recipient Organization	Kindred Bio
Country	United States
Start Date	Feb 26, 2021
End Date	Feb 25, 2022
Duration	364 days
Number of Grantees	1
Roles	Principal Investigator
Data Source	NIH (US)
Grant ID	`10490563`

Grant Description

The purpose of this task order is to re-supply recombinant human papillomavirus type 16 chimeric L1/L2 virus-like particles (VLPs) for use as a vaccine (HPV16L1/16RG1 VLP vaccine) in ongoing human clinical trials, through the tasks identified in the Statement of Work, dated 12/18/2020.